Janus faces of NF-κB: Neurodestruction versus neuroprotection

Nature Medicine

Volumn 3, Issue 1, 1997, Pages 20-22

  Lipton, Stuart A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTECTIVE AGENT;

BRAIN ISCHEMIA; CELL DEATH; CELL PROTECTION; CYTOTOXICITY; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD; APOPTOSIS; ASPIRIN; CELL DEATH; CEREBROVASCULAR DISORDERS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEURONS; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031022142     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0197-20     Document Type: Short Survey

References (15)

1. Lipton, S.A. & Rosenberg, P.A. Mechanisms of disease: Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622 (1994).
2. Grilli, M., Pizzi, M., Memo, M. & Spano, P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274, 1383-1385 (1996).
3. Kretz-Remy, C., Mehlen, P., Miralut, M.E. & Arrigo, A.P. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. J. Cell Biol. 133, 1083-1093 (1996).
4. Ankarcrona, M. et al. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973 (1995).
5. Lin, K.-I. et al. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell Biol. 131, 1149-1161 (1995).
6. Beg, A.A. & Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784 (1996).
7. Wang, C.-Y., Mayo, M.W. & Baldwin, A.S., Jr. TNF-and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science 274, 784-787 (1996).
8. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789 (1996).
9. Goodman, Y. & Mattson, M.P. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872 (1996).
10. Bauerle, P.A. & Baltimore, D. NF-κB: Ten years after. Cell 87, 13-20 (1996).
11. Obeid, L.M., Linardic, C.M., Karolak, L.A. & Hannun, Y.A. Programmed cell death induced by ceramide. Science 259, 1769-1771 (1993).
12. Verheij, M. et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380, 75-79 (1996).
13. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. & Greenberg, ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331 (1995).
14. Frade, J.M., Rodriguez-Tébar, A. & Barde, Y.-A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166-168 (1996).
15. Schutze, S., Wiegman, K., Machleidt, T. & Krönke, M. TNF-induced activation of NF-kappa B. Immunobiohgy 193, 193-203 (1995).